SCHEMBL30607283

C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O

nearest known ligand 0.63

Predicted protein targets (top 16)

	gene	UniProt	supporting neighbours	confidence
▸	MAPK8	P45983	1/20	0.63

▸	MAPK9	P45984	1/20	0.63

▸	MAPK10	P53779	1/20	0.63

▸	KDM1A	O60341	3/20	0.61

▸	NPY2R	P49146	8/20	0.60

▸	NPY4R	P50391	8/20	0.60

▸	NPY5R	Q15761	8/20	0.60

▸	NPY1R	P25929	6/20	0.60

▸	KEAP1	Q14145	1/20	0.59

▸	MAOB	P27338	1/20	0.58

▸	KDM5A	P29375	1/20	0.58

▸	KDM1B	Q8NB78	1/20	0.58

▸	TFPI	P10646	4/20	0.57

▸	CXCR4	P61073	1/20	0.57

▸	RAMP3	O60896	1/20	0.54

▸	CALCR	P30988	1/20	0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30262210	0.87	KDM1A (0.74)	MAPK8MAPK9MAPK10KDM1ANPY2R
SCHEMBL30607391	0.86	CXCR4 (0.64)	MAPK8MAPK9MAPK10NPY2RNPY4R
SCHEMBL30804666	0.86	NPY2R (0.64)	KDM1ANPY2RNPY4RNPY5RNPY1R
SCHEMBL1371717	0.85	KDM1A (0.71)	MAPK8MAPK9MAPK10KDM1ANPY2R
SCHEMBL30712941	0.85	MAPK8 (0.73)	MAPK8MAPK9MAPK10KDM1ANPY2R
SCHEMBL29393469	0.85	MAPK8 (0.73)	MAPK8MAPK9MAPK10KDM1ANPY2R
SCHEMBL30432934	0.84	MAPK8 (0.72)	MAPK8MAPK9MAPK10KDM1ANPY2R
SCHEMBL31182939	0.84	MAPK8 (0.73)	MAPK8MAPK9MAPK10KDM1ANPY2R
SCHEMBL30080584	0.84	MAPK8 (0.62)	MAPK8MAPK9MAPK10KDM1ANPY2R
SCHEMBL30726564	0.84	KDM1A (0.59)	MAPK8MAPK9MAPK10KDM1ANPY2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-12383505-B2	Nanoparticle for the remodeling of cancer-associated fibroblasts	UNIVERSITY OF SOUTH CAROLINA (US)	2025-08-12	—	—	US	disclosed
US-20230310331-A1	NANOPARTICLE FOR THE REMODELING OF CANCER-ASSOCIATED FIBROBLASTS	UNIVERSITY OF SOUTH CAROLINA (US)	2023-10-05	—	—	US	disclosed